LianBio

company

About

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$310M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
101 - 250
Operating Status
Active

LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$310M
LianBio has raised a total of $310M in funding over 2 rounds. Their latest funding was raised on Oct 29, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 29, 2020 Series A $310M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
LianBio is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Series A